跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,168 条关于
“IRIC”
全部
1,168
临床试验
1,112
药物
17
机构
7
资讯
32
去年
IRIC and Ipsen Initiate Phase 1 Trial of RAF Inhibitor IPN01195 for Solid Tumors
9个月前
Ipsen Expands Oncology Partnership with Université de Montréal and IRICoR, Adding Two MAP Kinase-Related Discovery Programs
去年
Epitopea's CryptoMap Platform Identifies Novel Immunotherapy Targets in Melanoma and NSCLC
去年
Epitopea Strengthens Leadership Team as RNA-Based Cancer Immunotherapy Platform Advances Toward Clinical Trials
去年
ORIC Pharmaceuticals Announces Promising Early Data for ORIC-944 and Collaboration for ORIC-114
10个月前
ORIC Pharmaceuticals Completes Dose Exploration for ORIC-944 in Prostate Cancer, Shows Promising Efficacy Signals
去年
Isatuximab-irfc (Sarclisa) Approved for Multiple Myeloma Treatment
去年
ORIC-114 Demonstrates Potential in Preclinical Cancer Study
去年
ORIC Pharmaceuticals Maintains Buy Rating Amidst Competitive Landscape
2年前
ORIC Pharmaceuticals Presents Promising Data on Cancer Drug Candidates at AACR Meeting
第 1 页,共 4 页
上一页
下一页